The changing characteristics of patients infected with chronic hepatitis C virus from 2014 to 2019: Real‐world data from the German Hepatitis C‐Registry (DHC‐R)-Reference-Cited by-同舟云学术

The changing characteristics of patients infected with chronic hepatitis C virus from 2014 to 2019: Real‐world data from the German Hepatitis C‐Registry (DHC‐R)

Published:2021-08-12 Issue:10 Volume:28 Page:1474-1483
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Hüppe Dietrich¹,Stoehr Albrecht²,Buggisch Peter²,Mauss Stefan³,Klinker Hartwig⁴,Teuber Gerlinde⁵,Hidde Dennis⁶,Lohmann Kristina⁶,Bondin Mark⁷,Wedemeyer Heiner⁸⁹¹⁰

Affiliation:

1. Gastroenterologische Gemeinschaftspraxis Herne Herne Germany

2. Institut für Interdisziplinäre Medizin Hamburg Germany

3. Centre for HIV and Hepatogastroenterology Duesseldorf Germany

4. Medizinische Klinik IIUniversitätsklinikum Würzburg Würzburg Germany

5. Practice PD Dr. med. G. Teuber Frankfurt am Main Germany

6. AbbVie Germany GmbH & Co. KG Wiesbaden Germany

7. AbbVie Inc North Chicago Illinois USA

8. Leberstiftungs‐GmbH Deutschland Hannover Germany

9. Klinik für Gastroenterologie Hepatologie und Endokrinologie Medizinische Hochschule Hannover Hannover Germany

10. Klinik für Gastroenterologie und Hepatologie Universitätsklinikum EssenUniversität Duisburg‐Essen Essen Germany

Funder

AbbVie

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jvh.13586

Reference40 articles.

1. World Health Organization (WHO).Global Hepatitis Report 2017.2017. Availableat:https://apps.who.int/iris/bitstream/handle/10665/255016/9789241565455‐eng.pdf;jsessionid=525893E0A2C6FEDEE194AAEBC45058A6?sequence=1Accessed September 2020.

2. Polaris Observatory.Germany HCV infections.2020. Available at:https://cdafound.org/dashboard/polaris/dashboard.htmlAccessed September 2020.

3. Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission

4. Real-world treatment for chronic hepatitis C infection in Germany: Analyses from drug prescription data, 2010–2015

5. Die Seroepidemiologie der Hepatitis A, B und C in Deutschland

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Efficacy and Safety of Universal 8-Week Glecaprevir/Pibrentasvir for Treatment-Naïve Patients from a Nationwide HCV Registry in Taiwan;Infectious Diseases and Therapy;2024-04-28

2. Changes in characteristics of patients with hepatitis C virus-related cirrhosis from the beginning of the interferon-free era;World Journal of Gastroenterology;2023-04-07

3. Effectiveness and safety of 8-week glecaprevir/pibrentasvir in HCV treatment-naïve patients with compensated cirrhosis: real-world experience from Taiwan nationwide HCV registry;Hepatology International;2023-03-27

4. Racial Disparity in HCV Demographics and Treatment Between Interferon Era (2002–2003) and Direct Acting Anti-viral Era (2019);Cureus;2023-03-24

5. Decade of optimizing therapy with direct-acting antiviral drugs and the changing profile of patients with chronic hepatitis C;World Journal of Gastroenterology;2023-02-14